GH SecretagoguesResearch OnlyD

GHRP-6

Growth Hormone Releasing Peptide-6

GHRP-6 is a synthetic hexapeptide growth hormone secretagogue that strongly stimulates GH release through ghrelin receptor activation. It is particularly notable for significantly increasing appetite via ghrelin pathway activation — useful in research contexts for body composition changes, catabolic state reversal, and GH deficiency studies. Research use only; not FDA-approved for therapeutic use.

XRedditFacebook
Observational report only — live community data. Not medical advice. Does not recommend doses, protocols, or treatments.
Studies cited
3
Research grade
D
Experience
93

Overall check-ins

Activity
85

Trackers & reports

Overview

About GHRP-6

GHRP-6 is a synthetic hexapeptide growth hormone secretagogue that strongly stimulates GH release through ghrelin receptor activation. It is particularly notable for significantly increasing appetite via ghrelin pathway activation — useful in research contexts for body composition changes, catabolic state reversal, and GH deficiency studies. Research use only; not FDA-approved for therapeutic use.

Category
GH Secretagogues
Regulatory status
Research Only
Also known as
Growth Hormone Releasing Peptide-6
Self-reports
6

Community

What 6 users report

6 community reports

Overall experience

From check-in ratings — separate from side effects logged below. Side effects are logged separately from overall experience. A favorable check-in can still include nausea, fatigue, or injection-site reactions.

Favorable 83% · Mixed 17% · Unfavorable overall 0%

Most reported benefits

Benefits users selected when logging a favorable or mixed check-in.

Appetite
6

Most logged side effects

Side effects are logged separately from overall experience. A favorable check-in can still include nausea, fatigue, or injection-site reactions.

Water retention
1

Self-reported dose per injection

Median bucket: 200–400 mcg · Most common: 200–400 mcg

Reports span 100–400 mcg

100–200
2
200–400
4

Anonymized self-reports from PeptIQ users — not prescribing guidance. Buckets group similar logged amounts; open-ended top buckets mean “at least” that dose.

Commonly stacked with

Research

Cited research (2)

Tools

Explore more

Explore

More ways to learn about GHRP-6 from observational PeptIQ data.

Compare with

Related peptides

Help

Frequently asked

What do PeptIQ users report about GHRP-6?

This page summarizes 6 anonymized self-reports from PeptIQ users who track GHRP-6, including commonly reported effects and co-tracked peptides. These are observational patterns, not clinical outcomes.

How do side effects relate to overall experience for GHRP-6?

PeptIQ separates overall check-in ratings (favorable, mixed, or unfavorable) from logged side effects like nausea or fatigue. Users often report benefits and side effects in the same check-in — a high experience score does not mean zero side effects were noted.

What research is cited for GHRP-6?

2 sources are linked on this page, including PubMed articles, clinical trial registries, and FDA labels where applicable. Citations describe published research — not recommendations.

Is GHRP-6 safe to use?

This wiki does not assess safety or recommend use. GHRP-6 is listed as Research Only. Consult a licensed clinician for personal medical decisions.

What are the purported benefits and uses of GHRP-6?

Research, primarily in animal models, suggests GHRP-6 may have a wide range of therapeutic potentials due to its ability to promote angiogenesis (formation of new blood vessels), stimulate collagen synthesis, and modulate inflammatory responses.

Source

What is the legal status of GHRP-6?

GHRP-6 is not approved by the FDA for any human use. There is no legal basis for selling it as a drug, food, or dietary supplement in the United States. The FDA has classified GHRP-6 as a Category 2 bulk drug substance, which explicitly prohibits licensed compounding pharmacies from using it in compounded medications.

Source

What are the known or theoretical side effects and risks of GHRP-6?

The safety and effectiveness of GHRP-6 have not been thoroughly evaluated in humans through rigorous clinical trials. This lack of human data means that safe dosages, short-term side effects, and long-term health consequences are largely unknown.

Source

What is the current state of research on GHRP-6?

While there are over 200 published studies on GHRP-6, the vast majority are animal or in vitro (cell) studies. These preclinical studies consistently show positive results across various tissue types. However, there is a significant lack of comprehensive human clinical trial data.

Source